The American College of Chest Physicians (CHEST) recently released a new clinical guideline on the management of patients ...

The research team led by Senior Researchers Yoonhee Lee from the Division of Biomedical Technology and Gyogwon Koo from the ...

New research identifies NF-kappa-B-activating protein-like (NKAPL) as a potent tumor suppressor in non-small cell lung cancer ...

Non-small cell lung cancer (NSCLC) accounts for over 80% of lung cancer cases and is often diagnosed at advanced stages, ...

While chemotherapy remains a cornerstone of lung cancer treatment, it often weakens the immune system it relies on for ...

Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone.

The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.

The global companion diagnostics market is set to surge from USD 7.03 Billion in 2024 to USD 22.83 Billion by 2034, driven by rising cancer prevalenc ...

Synchronous twin malignancies, defined as the simultaneous occurrence of two distinct primary cancers in the same patient, ...

Explore how artificial intelligence is changing cancer care and what it means for the future of precision oncology.